INS and obesity disorder: Peripherally, asprosin induces hepatic glucose production and directly affects insulin signaling, leading to insulin resistance, inflammation, and endoplasmic reticulum stress, leading to lipid metabolism disorders and the onset of obesity [21, 39, 41].